Trulieve Reports Q2 Revenue of $271 Million, Adjusted EBITDA of $98 Million
Trulieve reported second-quarter 2026 revenue of $271 million, a 60% gross margin and adjusted EBITDA of $98 million. Management said Q3 revenue is expected to be comparable to the medical-only business’s Q2 revenue of $222 million.